Cpd. 37
Selleck Chemicals
SKU:E4750-5MG
Couldn't load pickup availability
Cpd. 37 is an inhibitor of MYC used in studies of Cell Cycle Regulation. In practice, this places the compound in experiments that measure checkpoint control, mitotic progression, and proliferation timing in cancer and cell cycle models.
By inhibiting MYC, Cpd. 37 can be used to examine checkpoint control, mitotic progression, and proliferation timing. This context is compatible with cell-cycle, mitotic, and proliferation assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In cancer and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving MYC
- Pathway perturbation studies connected to Cell Cycle Regulation
- Concentration-response inhibition and target-dependence studies
- Phenotypic profiling in cancer and cell cycle models
Overall, Cpd. 37 is appropriate when a defined chemical perturbant is needed to connect MYC with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- MYC
- Target Class:
- Other
- Pathways:
- Cell Cycle Regulation
- Research Area:
- Cancer • Cell Cycle
- CAS No.:
- 3042878-82-7
- Molecular Weight:
- 543.89
- Formula:
- C₂₅H₂₀ClF₆N₃O₂
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.